Gbola Amusa News
-
Novartis AG’s troubled acquisition of Chiron Corp.’s vaccine business has one last hope -- approval of a shot to protect against a meningitis-causing bacteria.
-
GlaxoSmithKline Plc, maker of Advair, the world’s best-selling drug for smoker’s cough and asthma, is considering a three-in-one treatment delivered in a single device to stay ahead of competitors such as Novartis AG.
-
GlaxoSmithKline Plc may find its next acquisition target where the U.K. drugmaker found the last two: among more than a dozen companies it collaborates with to develop new treatments.
-
GlaxoSmithKline Plc agreed to pay $3 billion to settle U.S. criminal and civil investigations into whether the company marketed drugs for unapproved uses and other matters.
-
GlaxoSmithKline Plc said its Promacta blood disorder medicine eradicated hepatitis C in 23 percent of patients in a clinical trial.
-
Roche Holding AG may get the first signs at a cardiology conference this month that the Swiss drugmaker can garner $6.8 billion in sales with a pill to combat heart disease by raising so-called good cholesterol.
-
GlaxoSmithKline Plc agreed to pay about $460 million to resolve a majority of lawsuits alleging the company’s Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said.
-
GlaxoSmithKline Plc reported first- quarter profit that beat analysts’ estimates, boosted by sales of a vaccine for pandemic influenza.
-
GlaxoSmithKline Plc agreed to pay about $60 million in the first settlements of lawsuits alleging the company’s Avandia diabetes drug causes heart attacks and strokes in some users, people familiar with the accords said.
-
The California Public Employees Retirement System sued former Lehman Brothers Holdings Inc. executives and underwriters alleging they hid Lehman’s exposure to subprime loans when they sold the pension fund about $700 million in bonds.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page